Sponsored by:

Molecular Imaging: Page 451

Siemens debuts Symbia E
By AuntMinnie.com staff writers
Siemens Medical Solutions is introducing its Symbia E series SPECT camera at this week's European Association of Nuclear Medicine (EANM) annual congress in Copenhagen, Denmark.
October 14, 2007
NAS/IOM report sees hope and despair for nuclear medicine
By Cynthia E. Keen
Nuclear medicine is at a crossroads in the U.S., according to a new report by the National Academy of Sciences (NAS) and the Institute of Medicine (IOM). The result of a 13-month study by a multidisciplinary team of experts, the report conveys optimism for future innovations and applications in nuclear medicine, but also reaches some sobering conclusions unless changes occur with research funding, radionuclide availability and cost, federal agency management, and the shortage of trained specialists and experts.
October 14, 2007
German-U.S. team successfully tests PET ring inside MRI system
By Wayne Forrest
German and U.S. researchers and engineers are showing early success with a prototype hybrid PET/MRI system, which features a full-ring PET insert installed inside a 7-tesla MR scanner. The team from the University of Tübingen, Burker BioSpin MRI, and Siemens Preclinical Solutions recently presented the results of its study on the performance of the hybrid PET/MRI small animal imaging system.
October 9, 2007
ACRIN, GOG launches cervical cancer study
By AuntMinnie.com staff writers
The American College of Radiology Imaging Network (ACRIN) and the Gynecologic Oncology Group (GOG) have begun a study to evaluate two imaging modalities for identifying pelvic and abdominal lymph node metastases in patients with locoregionally advanced cervical cancer.
October 8, 2007
Covidien partners with UNSW on imaging agent
By AuntMinnie.com staff writers
Covidien of Mansfield, MA, has signed a license agreement to develop a radiolabeled molecular imaging agent to evaluate the efficacy of cancer treatments with NewSouth Innovations, the technology transfer unit of the University of New South Wales (UNSW) in Sydney, Australia.
October 7, 2007
InSite One enters nuclear medicine market
By AuntMinnie.com staff writers
Archiving services provider InSite One of Wallingford, CT, has signed a co-marketing agreement with Technology Imaging Services (TIS), a company that serves the nuclear medicine, nuclear cardiology, and PET equipment market.
October 4, 2007
Avid launches clinical trial
By AuntMinnie.com staff writers
Molecular imaging developer Avid Radiopharmaceuticals said that enrollment has begun in a phase I clinical trial investigating the firm's F-18 AV-133 compound.
October 2, 2007
Molecular Insight buys manufacturing site
By AuntMinnie.com staff writers
Molecular Insight Pharmaceuticals has completed the previously announced purchase of a radiopharmaceutical manufacturing facility in Denton, TX.
October 2, 2007
GE introduces biopharmaceutical line
By AuntMinnie.com staff writers
GE Healthcare of Chalfont St. Giles, U.K., has introduced a new line of systems and devices for biopharmaceutical production.
October 1, 2007
Gamma Medica sells units in Switzerland
By AuntMinnie.com staff writers
Gamma camera developer Gamma Medica-Ideas of Northridge, CA, has installed several of its preclinical imaging systems at research institutes in Switzerland.
October 1, 2007
FDG-PET CAD scheme boosts diagnostic accuracy for Alzheimer's
By Wayne Forrest
With the number of cases of Alzheimer's disease and other dementias expected to rise over the next 10 years, researchers are looking for ways to improve diagnostic accuracy. In a new study, researchers used an artificial neural network (ANN) computer-aided detection (CAD) scheme with FDG-PET for Alzheimer's disease with multicenter data, and found it was able to enhance diagnostic accuracy.
October 1, 2007
GE, Lilly join forces
By AuntMinnie.com staff writers
GE's research and development organization, GE Global Research, has partnered with pharmaceutical giant Eli Lilly in a three-year collaborative research agreement to discover and develop in vitro diagnostic assays for predicting cancer treatment response to targeted therapies.
September 30, 2007
Previous Page
Page 451 of 611
Next Page